MRVI - Maravai Lifesciences Holdings  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MRVI is currently covered by 11 analysts with an average price target of $7.78. This is a potential upside of $3.36 (76.02%) from yesterday's end of day stock price of $4.42.

Maravai Lifesciences Holdings 's activity chart (see below) currently has 40 price targets and 63 ratings on display. The stock rating distribution of MRVI is 60.98% BUY and 39.02% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.22% with an average time for these price targets to be met of 81.73 days.

Highest price target for MRVI is $10, Lowest price target is $7, average price target is $7.78.

Most recent stock forecast was given by CATHERINE RAMSEY SCHULTE from BAIRD on 08-Nov-2024. First documented stock forecast 15-Dec-2020.

Currently out of the existing stock ratings of MRVI, 25 are a BUY (60.98%), 16 are a HOLD (39.02%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$9

$4.58 (103.62%)

$10

9 days ago
(08-Nov-2024)

3/4 (75%)

$4.2 (87.50%)

37

Hold

$7

$2.58 (58.37%)

$8

1 months 9 days ago
(08-Oct-2024)

10/11 (90.91%)

$-0.81 (-10.37%)

63

Buy

$10

$5.58 (126.24%)

$11

3 months 4 days ago
(13-Aug-2024)

3/12 (25%)

$1.56 (18.48%)

133

Buy

$10

$5.58 (126.24%)

$11

8 months 25 days ago
(23-Feb-2024)

4/7 (57.14%)

$1.64 (19.62%)

115

Buy

$10

$5.58 (126.24%)

$17

11 months 5 days ago
(12-Dec-2023)

1/2 (50%)

$4.41 (78.89%)

150

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MRVI (Maravai Lifesciences Holdings ) average time for price targets to be met?

On average it took 81.73 days on average for the stock forecasts to be realized with a an average price target met ratio 54.22

Which analyst has the current highest performing score on MRVI (Maravai Lifesciences Holdings ) with a proven track record?

TEJAS SAVANT

Which analyst has the most public recommendations on MRVI (Maravai Lifesciences Holdings )?

Tejas Savant works at MORGAN STANLEY and has 17 price targets and 9 ratings on MRVI

Which analyst is the currently most bullish on MRVI (Maravai Lifesciences Holdings )?

Erin Wright with highest potential upside - $39.7

Which analyst is the currently most reserved on MRVI (Maravai Lifesciences Holdings )?

Paul Knight with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?